Neurol Neuroimmunol Neuroinflamm 2022 Sep 21;9(5). Epub 2022 Jun 21.
From the Department of Neurology (S.F., C.W., L.T., K.M.B., S.V.), University of Texas Southwestern Medical Center, Dallas, TX; and Department of Neurology (R.N.), Barrow Neurological Institute, Phoenix, AZ.
Background And Objectives: Anti-N-methyl d-aspartate receptor (NMDAR) encephalitis classically affects women of childbearing age, producing a disproportionate number of pregnant women with anti-NMDAR encephalitis. The typical presentation includes progressive neuropsychiatric symptoms, seizures, and alterations in consciousness, all of which present potential risks to the fetus. First-line and second-line treatments similarly pose teratogenic potential; therefore, randomized studies with supportive data on pregnancy and fetal outcomes are lacking. Read More